Feed XBIT
XB
XBiotech Inc. XBIT NASDAQ · Healthcare · United States
$1.95 -1.02% -$0.02
Summary
49 / 100 · Bulios Score
Valuation 100Growth 0Profitability -Quality 0Debt 100Stability 58
What speaks for it
- It has no debt and holds $109.5M in cash.
What to watch
- It passes only 1 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 8 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapIs it growing?
It is shrinkingRevenue (USD)
20212022202320242025
Diluted EPS (USD)
20212022202320242025
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $45.1M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $109.5M
Debt $0.00
Free cash flow over 12 months -$40.8M
It has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2022By product
- Manufacturing Revenue 100%
By region
The company reports no revenue by region.
Manufacturing Revenue brings in 100% of revenue.
Segments in detail